Single-dose Solution For BRD - Flovuxin® - Launched By Krka
6th June, 2023 10h43
Krka has announced the launch of Flovuxin®, a fast-acting acting, injectable solution for bovine respiratory disease (BRD) caused by Mannheimia haemolytica, Pasteurella multocida, Mycoplasma bovis and Histophilus somni, associated with pyrexia¹.
Flovuxin is a combined formulation of florfenicol and flunixin, which delivers effective treatment for bovine respiratory infections via a single dose. Manufactured by Krka at its European production plant, Flovuxin offers treatment efficacy combined with improved value to vet practices and convenience on farm.
Krka’s Farm Key Account Manager Charlotte Read highlights: “BRD remains a priority issue on farm and advising farmers on the management of BRD risks, and treatment options when needed, is a key task for farm vets. Flovuxin’s combined formulation is a high efficacy BRD treatment acting within six hours2, to improve treatment outcomes.”
Will Ridgway, UK National Sales Manager, adds: “The Krka sales team is delighted to bring farm vets this new addition to our BRD treatment range, which already includes Fenflor® and Tuloxxin®. The Flovuxin launch is further confirmation of Krka’s commitment to work with vets and farmers to understand the everyday challenges they face and to provide effective, flexible and affordable solutions.”
Krka UK is the fastest growing animal health company in the United Kingdom3 and is a subsidiary of Slovenia-based Krka, d. d. Novo Mesto, a world leader in generic pharmaceuticals for both human and animal health. Working closely with customers, Krka supplies licensed medicines that deliver effective and consistent performance in clinical practice. Krka’s Animal Health Portfolio provides high efficacy pharmaceuticals for both companion and food producing animals covering parasite control, antibiotics and pain relief. Key brands include Milprazon CHEWABLE® and Prinocate®, for parasite management in cats and dogs, and Tolracol® for coccidiosis prevention on farm.
1 Refer to SPC for full details
2 Julien Thiry, Laura Elvira Partida, Juan Vicente GonzálezMartín, Eric Pagot, Florian Voisin, Hubert Theys, Guillaume Lequeux, Allan Weingarten, Vincent de Haas (2014); Treatment of naturally occurring bovine respiratory disease in juvenile calves with a single administration of a florfenicol plus flunixin meglumine formulation; The Veterinary record 174(17)
3 Kynetec UK Vet Data November 2022
For further information:
Rebecca George, George PR
Tel: 01449 737281/07974 161108
Email: [email protected]
More from KRKA
- 2022 Young Dairy Vet of the Year Announced
- Krka launches first line antibiotic Cladaxxa® in its companion animal range
- Krka Expands Sales Team with new South East Account Manager
- Experienced Vet Nurse Joins Krka as Account Manager for the North of England
- New Milprazon® CHEWABLE Range Eases Year-round Worming Compliance